[Monoamines and choreic syndromes].
作者信息
Constantinidis J
出版信息
Rev Neurol (Paris). 1972 Jul;127(1):65-77.
PMID:4272133
Abstract
摘要
相似文献
1
[Monoamines and choreic syndromes].
Rev Neurol (Paris). 1972 Jul;127(1):65-77.
2
[Specific therapy of extrapyramidal-motor syndromes].
Bibl Psychiatr Neurol. 1969;139:705-11.
3
[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
Med Klin. 1969 Aug 15;64(33):1451-6.
4
Editorial: Dopamine and G.A.B.A. in Huntington's chorea.
Lancet. 1974 Nov 9;2(7889):1122-3.
5
Drug-induced extrapyramidal disorders.
Res Publ Assoc Res Nerv Ment Dis. 1972;50:448-71.
6
The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Mod Trends Neurol. 1975;6:141-66.
7
Risks vs. benefits of antipsychotic drugs.
N Engl J Med. 1973 Aug 23;289(8):427-8. doi: 10.1056/NEJM197308232890812.
8
[Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
Riv Sper Freniatr Med Leg Alien Ment. 1966 Oct 31;90(5):1243-58.
9
Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
Am J Psychiatry. 1968 Feb;124(8):Suppl:40-8. doi: 10.1176/ajp.124.8S.40.
10
Drug treatment of diseases characterized by abnormal movements.
Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.
引用本文的文献
1
Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
Neurosci Behav Physiol. 1985 Mar-Apr;15(2):132-9. doi: 10.1007/BF01186980.
Zotero 插件